The Stock in Madurna Went Down Because of the New Omnicron Variant

The stock fell because a federal circuit court of appeals, a panel of three judges upheld a ruling against the biota company in decision on patents that arbutus bioparma set it owns. The patents in question regard limpid nano particles, which are used to deliver m r n a to sell safely. Which basically means, if you've got stock in maderna, they don't own the rights to that product. And i can only imagine the have to pay out some kind of portion of their revenue to the rights holder on this regard. That plus two judges now ruling against byden's vaccine mandate, plus his latest statements, all of course, are having a kind of c